Preferential uptake of intravenously administered hyaluronidase (Hyalosidase) by damaged rat myocardium

Bioscience Reports
|April 1, 1985
PubMed

Insights

This study shows that 125I-labelled hyaluronidase is preferentially taken up by damaged heart tissue in a rat model of myocardial infarction. This enzyme may be useful for targeting damaged areas in the heart.

Area of Science:

  • Cardiology
  • Biochemistry
  • Pharmacology

Background:

  • Myocardial infarction (MI) is a leading cause of death worldwide.
  • Accurate diagnosis and targeted therapy for MI remain critical challenges.

Purpose of the Study:

  • To establish a rat model of myocardial infarction.
  • To investigate the biodistribution of 125I-labelled hyaluronidase in this model.

Main Methods:

  • Myocardial infarction was induced in rats by left-anterior coronary artery ligation.
  • Plasma levels of creatine kinase, aspartate aminotransferase, and lactate dehydrogenase were measured to confirm MI.
  • 125I-labelled hyaluronidase was administered intravenously, and its uptake in damaged and normal myocardium was assessed.

Main Results:

  • Successful induction of myocardial infarction was confirmed by elevated cardiac enzyme levels.
  • Intravenous administration of 125I-labelled hyaluronidase resulted in significantly higher uptake in the damaged myocardium compared to normal heart tissue.

Conclusions:

  • The established rat model reliably replicates key features of human myocardial infarction.
  • 125I-labelled hyaluronidase demonstrates preferential accumulation in infarcted cardiac tissue, suggesting potential as a diagnostic or therapeutic agent.

Related Concept Videos